Most-Downgraded Stocks NASDAQ:ILMN Illumina - ILMN News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $219.77 -4.78 (-2.13%) (As of 03/20/2023 12:00 AM ET) Add Compare Share Share Today's Range$216.85▼$223.8250-Day Range$193.75▼$228.1552-Week Range$173.45▼$371.16Volume1.14 million shsAverage Volume1.41 million shsMarket Capitalization$34.72 billionP/E RatioN/ADividend YieldN/APrice Target$249.40 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address ILMN Media Mentions By Week ILMN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ILMN News Sentiment▼-0.170.35▲Average Medical News Sentiment ILMN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ILMN Articles This Week▼209▲ILMN Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineA. D. Beadell Investment Counsel Inc. Purchases Shares of 1,002 Illumina, Inc. (NASDAQ:ILMN)marketbeat.com - March 20 at 9:00 AMStonnington Group LLC Cuts Position in Illumina, Inc. (NASDAQ:ILMN)marketbeat.com - March 19 at 9:19 AMS.A. Mason LLC Reduces Stock Position in Illumina, Inc. (NASDAQ:ILMN)marketbeat.com - March 17 at 11:26 AMIllumina, Inc. (NASDAQ:ILMN) Given Consensus Recommendation of "Hold" by Brokeragesmarketbeat.com - March 17 at 3:23 AMIllumina, Inc. (NASDAQ:ILMN) Shares Sold by West Oak Capital LLCmarketbeat.com - March 16 at 9:45 AMS&P 500 Losers: First Republic Crashes; Dow Giant Microsoft Slidesfinance.yahoo.com - March 20 at 5:44 PMBiotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail dealcnbc.com - March 20 at 3:30 PMIllumina (NASDAQ:ILMN) Given New $300.00 Price Target at Royal Bank of Canadaamericanbankingnews.com - March 19 at 4:22 AMIcahn proposes three candidates for Illumina’s board — Here’s what could be next in the battlecnbc.com - March 18 at 10:31 AMIllumina Should Heed Carl Icahn, Give Up on Grailfinance.yahoo.com - March 17 at 5:29 PMUPDATE 1-Carl Icahn urges Fed to keep fighting inflation after SVB collapse - FTfinance.yahoo.com - March 17 at 1:49 AMIllumina Inc. stock falls Tuesday, underperforms marketmarketwatch.com - March 16 at 4:53 AMIllumina Inc. stock rises Wednesday, outperforms marketmarketwatch.com - March 16 at 4:53 AMIllumina retains ‘Buy’ rating from Canaccord as activist investor Carl Icahn prepares for face-offproactiveinvestors.com - March 16 at 4:53 AMIcahn urges Illumina to unwind Grail deal, pushes ahead on proxy fightca.finance.yahoo.com - March 15 at 5:20 PMIllumina slaps back at activist investor Carl Icahn over Grail, board seatsbizjournals.com - March 14 at 8:50 PMSVB May Be a Failure of Supervision. What It Means for Other Banks.finance.yahoo.com - March 14 at 10:12 AMIllumina launches its first product enabling long- and short-read sequencing on one instrumentfinance.yahoo.com - March 14 at 10:12 AMIllumina Surges As Activist Investor Carl Icahn Attempts To Wrest Controlfinance.yahoo.com - March 13 at 6:30 PMIllumina jumps 20% as Carl Icahn starts proxy battle over Grail deal (update)seekingalpha.com - March 13 at 2:36 PMIllumina, Seagen And Other Big Stocks Moving Higher On Mondaybenzinga.com - March 13 at 12:31 PMILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illuminainvestorplace.com - March 13 at 12:03 PMCarl Icahn Issues Open Letter to Illumina :investing.com - March 13 at 10:54 AMWSJ: Carl Icahn says Grail deal cost Illumina shareholders $50 billionfinance.yahoo.com - March 13 at 8:40 AMUPDATE 1-Carl Icahn prepares for proxy fight at Illumina - WSJfinance.yahoo.com - March 12 at 10:39 PMCarl Icahn prepares for proxy fight at Illumina - WSJfinance.yahoo.com - March 12 at 10:39 PMCarl Icahn Prepares for Proxy Fight at Illuminawsj.com - March 12 at 10:17 PMCarl Icahn Plans Illumina Proxy Fight - WSJinvesting.com - March 12 at 9:51 PMChildren’s Mercy Kansas City Tackles the Unique Complexity of Pediatric Cancerfinance.yahoo.com - March 10 at 6:48 PMHow Is The Market Feeling About Illumina?msn.com - March 7 at 5:49 AMA Look Into Illumina's Debtmsn.com - March 7 at 5:49 AMMyriad Genetics' (MYGN) New Pact to Extend HRD Testing Accessfinance.yahoo.com - March 3 at 5:07 PMA New Genomic Atlas Could Help Save Endangered Elephantsfinance.yahoo.com - March 2 at 1:43 PMWorking To Solve Rare Disease and Support Patientsfinance.yahoo.com - February 28 at 1:35 PMJohn Hancock expands access to Galleri®, GRAIL's breakthrough cancer screening technologyfinance.yahoo.com - February 23 at 9:38 AMStartups Take On Illumina in Race for Cheaper DNA Sequencingfinance.yahoo.com - February 16 at 7:17 PMContinue To Avoid Illumina Incseekingalpha.com - February 16 at 7:52 AMUsing Whole-Genome Sequencing To Study Early-Onset Parkinson’s Diseasefinance.yahoo.com - February 15 at 2:06 PMIllumina Faces Rival Gene Sequencers and Price Competitionfinance.yahoo.com - February 14 at 2:59 PMIllumina Receives Highest Distinction in the 2023 S&P Global Sustainability Yearbookfinance.yahoo.com - February 10 at 1:17 PMIllumina, Inc. (NASDAQ:ILMN) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - February 9 at 8:28 PMA New Era for Discoveries at Admera Healthfinance.yahoo.com - February 9 at 3:27 PMIllumina delivers first NovaSeq X Plus sequencer to the Broad Institutefinance.yahoo.com - February 8 at 1:41 PMThe Brazilian billionaires embroiled in a $3.9bn scandalfinance.yahoo.com - February 8 at 8:40 AMIllumina (ILMN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimatesfinance.yahoo.com - February 8 at 8:40 AMOxford Nanopore: Illumina's Formidable Challengerseekingalpha.com - February 8 at 2:45 AMThe Wild Card That Keeps Haunting DNA-Reading Giant Illuminafinance.yahoo.com - February 7 at 10:14 PMIllumina (ILMN) Misses Q4 Earnings Estimatesfinance.yahoo.com - February 7 at 10:14 PMIllumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022finance.yahoo.com - February 7 at 5:13 PMDNA-Reading Giant Illumina Topples On Wide Profit Missfinance.yahoo.com - February 7 at 5:13 PMIllumina Attracts Challengers for DNA Sequencing Ahead of Earningsfinance.yahoo.com - February 7 at 2:11 AMIllumina, Pacific Biosciences, And Oxford Nanopore Market Position Comparisonseekingalpha.com - February 6 at 3:00 AMHow Organizations Around the World Are Closing the Cancer Care Gapfinance.yahoo.com - February 3 at 12:54 PMIllumina Named to Bloomberg Gender Equality Index for Fifth Consecutive Yearfinance.yahoo.com - February 1 at 1:48 PMVideo: UK Festival of Genomics & Biodata Inspires and Connects Genomics Leadersfinance.yahoo.com - January 31 at 2:57 PM Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:ILMN) was last updated on 3/20/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.